Skip to main content
Clinical Trials/DRKS00022304
DRKS00022304
Recruiting
N/A

A prospective pilot study on the safety and feasibility of sentinel node biopsy in the neck management of conventionally assessed lymph node negative sinonasal squamous cell carcinoma - SentiNose Pilot

niversitätsklinikum Ulm, Kliniken am oberen Eselsberg0 sites25 target enrollmentNovember 13, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
C30.0
Sponsor
niversitätsklinikum Ulm, Kliniken am oberen Eselsberg
Enrollment
25
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 13, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Ulm, Kliniken am oberen Eselsberg

Eligibility Criteria

Inclusion Criteria

  • Histologically proven malignancy of the nasal vestibulum and the sinonasal tract; T1\-3, N0, M0; squamous cell carcinoma
  • Primary tumor must be resectable endoscopically or via limited open approach without changing the facial appearance
  • Written and signed informed consent
  • ECOG PS \=2, Karnofsky PS \= 60 %
  • Age \= 18
  • Curative treatment intent

Exclusion Criteria

  • Prior head and neck malignancy
  • Entity other than squamous cell carcinoma
  • Clinically suspected lymph node or distant metastases
  • Serious co\-morbidity, e.g. high\-grade carotid artery stenosis, congestive heart failure NYHA grade 3 and 4, liver cirrhosis CHILD C
  • Hemoglobin level \< 9\.5 g/dl
  • Pregnancy or lactation
  • Prior treatment of the neck of any cause
  • Concurrent treatment with experimental drugs or participation in another clinical trial of any kind within 30 days prior to study screening
  • Social situations that limit compliance with study requirements or patients with an unstable condition (e.g., psychiatric disorder, a recent history of drug or alcohol abuse, interfering with study compliance, within 6 months prior to screening) or otherwise thought to be unreliable or incapable of complying with the requirements of the protocol
  • Patients institutionalized by official means or court order

Outcomes

Primary Outcomes

Not specified

Similar Trials